Search

everythinglearnresearchcommunity

for

Search:↓

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Effective vaccines and treatments are crucial for long-term COVID-19 control.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Older males had higher death rates, and Latin Americans were more often in the ICU during the COVID-19 outbreak in a Spanish hospital.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

Long COVID causes lasting symptoms and needs vaccines for prevention and a team approach for treatment.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Low testosterone and SHBG levels are linked to higher COVID-19 death rates.

Testosterone's effects on COVID-19 are unclear and need more research.

Canakinumab's effect on COVID-19 outcomes is unclear.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Lithium poisoning can cause severe health complications and requires careful monitoring.

Many hospitalized COVID-19 patients still have symptoms like fatigue and hair loss up to a year later, especially older, lower-income individuals with other health issues.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Men are more at risk for severe COVID-19 due to biological differences, suggesting the need for targeted treatments.

Natural products may be safer and effective alternatives for managing heart attacks.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Antiandrogens don't help with COVID-19 and aren't recommended.

Cepharanthine dry powder inhalers may effectively treat acute lung injury by reducing inflammation.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

New genetic mutations linked to rare skin disorders were found in three newborns.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.